These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10610684)

  • 21. Optimization of plasma fluorogenic thrombin-generation assays.
    Chandler WL; Roshal M
    Am J Clin Pathol; 2009 Aug; 132(2):169-79. PubMed ID: 19605810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
    Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
    Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
    He S; Xiong S; He R; He X; Liu F; Han J; Li J
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):118-21. PubMed ID: 11876967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma.
    Nieuwenhuys CM; Feijge MA; Béguin S; Heemskerk JW
    Thromb Haemost; 2000 Dec; 84(6):1045-51. PubMed ID: 11154112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram.
    Takamiya O; Sakata M
    Lab Hematol; 2008; 14(4):39-44. PubMed ID: 19095614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin generation.
    Berry LR; Chan AK
    Methods Mol Biol; 2013; 992():139-54. PubMed ID: 23546711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative aspects of blood coagulation.
    Gentry PA
    Vet J; 2004 Nov; 168(3):238-51. PubMed ID: 15501141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
    Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
    Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intrinsic coagulation activity assay.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin generation and plasma dilution.
    Hemker HC; De Smedt E; Chandler WL; Roshal M
    Am J Clin Pathol; 2010 Jan; 133(1):163; author reply 164. PubMed ID: 20023273
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
    Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of whole blood in thrombin generation in contact with various titanium surfaces.
    Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
    Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of maximum thrombin generation capacity in blood and plasma using the thrombin generation assay (THROGA).
    Nowak G; Lange U; Wiesenburg A; Bucha E
    Semin Thromb Hemost; 2007 Jul; 33(5):508-14. PubMed ID: 17629848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants.
    Liestøl S; Sandset PM; Jacobsen EM; Mowinckel MC; Wisløff F
    Br J Haematol; 2007 Jan; 136(1):131-7. PubMed ID: 17092306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.